Wong CK, McLean BA, Baggio LL, Koehler JA, Hammoud R, Rittig N, et al
Mild mouth irritation is possible with some formulations
Donoho and Ferguson argue that Hims pattern of describing the compounded product as having the same active ingredient as Novos drugs is misleading because, although both products contain semaglutide, Hims synthetic manufacturing process allegedly produces a materially different active ingredient with additional peptide impurities, rendering the same active ingredient claim false and misleading
Neuropsychiatric association of tirzepatide and semaglutide in obesity with and without type 2 diabetes
Dosage and Administration Differences The dosages and frequency of administering the peptide also vary between both delivery methods
A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report